PODD

Insulet Corp

Investor Moves

InvestorPortfolio ValuePortfolio ChangePosition ChangeAvg Buy PriceCurrent Price
Baillie GiffordInvestor
$426M2M shares
TrimQ1 2026
$156M
$209.84
$146.01

Insider Trades

ActorHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Borio LucianaDirector
--1.7k shares
Grant / ExerciseMay 20, 2026
Disclosure amount unavailable1.7k shares
--
$146.01
Borio LucianaDirector
--1.7k shares
Grant / ExerciseMay 20, 2026
Disclosure amount unavailable1.7k shares
--
$146.01
Frederick Wayne A.I.Director
--1.7k shares
Grant / ExerciseMay 20, 2026
Disclosure amount unavailable1.7k shares
--
$146.01
Frederick Wayne A.I.Director
--1.7k shares
Grant / ExerciseMay 20, 2026
Disclosure amount unavailable1.7k shares
--
$146.01
Hopfield JessicaDirector
--1.7k shares
Grant / ExerciseMay 20, 2026
Disclosure amount unavailable1.7k shares
--
$146.01
Hopfield JessicaDirector
--1.7k shares
Grant / ExerciseMay 20, 2026
Disclosure amount unavailable1.7k shares
--
$146.01

News

seekingalpha.comInsulet Corporation Valuation Pressure Has Dropped Enough (Upgrade)seekingalpha.comJun 8gurufocus.comInsulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Caregurufocus.comJun 6zacks.comWhy Is Insulet (PODD) Down 8.7% Since Last Earnings Report?zacks.comJun 5fool.comDexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026?fool.comJun 4businesswire.comInsulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific Sessionsbusinesswire.comJun 4